RET Fusion mutation drugs – lung cancer

Activated RET and ROS: two new driver mutations in lung adenocarcinoma http://tlcr.amegroups.com/article/view/1031/1683

Anti-aging combo on Amazon

Amazon links. N (R) Niagen Nicotinamide Riboside https://www.amazon.com/Niagen-Nicotinamide-Riboside-60-capsules/dp/B00L5Q951S/ref=sr_1_2_s_it?s=hpc&ie=UTF8&qid=1474577659&sr=1-2&keywords=niagen Pterostilbene Longevity and Antioxidant Supplement https://www.amazon.com/Pterostilbene-Resveratrol-Longevity-Antioxidant-Supplement/dp/B00JQS5T76/ref=sr_1_2_s_it?s=hpc&ie=UTF8&qid=1474577726&sr=1-2&keywords=Pterostilbene Pterostilbene inhibits lung cancer through induction of apoptosis. http://www.ncbi.nlm.nih.gov/pubmed/20031166   NAD+ and SIRT1: Their Role In Chronic Health Issues

Cancer Notes

Targeting mTOR in RET mutant medullary and differentiated thyroid cancer cells http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375728/ Inhibitors of RET, a tyrosine kinase receptor encoded by a gene that is frequently mutated in medullary thyroid cancer, have emerged as promising novel therapies for the disease. Rapalogs and other mammalian target of rapamycin (mTOR) inhibitors are effective agents in patients with […]